203 related articles for article (PubMed ID: 17971664)
1. A novel panel of cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer's disease versus normal aging and frontotemporal dementia.
Simonsen AH; McGuire J; Podust VN; Hagnelius NO; Nilsson TK; Kapaki E; Vassilopoulos D; Waldemar G
Dement Geriatr Cogn Disord; 2007; 24(6):434-40. PubMed ID: 17971664
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease.
Simonsen AH; McGuire J; Podust VN; Davies H; Minthon L; Skoog I; Andreasen N; Wallin A; Waldemar G; Blennow K
Neurobiol Aging; 2008 Jul; 29(7):961-8. PubMed ID: 17321007
[TBL] [Abstract][Full Text] [Related]
3. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease.
Lewczuk P; Esselmann H; Groemer TW; Bibl M; Maler JM; Steinacker P; Otto M; Kornhuber J; Wiltfang J
Biol Psychiatry; 2004 Mar; 55(5):524-30. PubMed ID: 15023581
[TBL] [Abstract][Full Text] [Related]
4. Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment.
Simonsen AH; McGuire J; Hansson O; Zetterberg H; Podust VN; Davies HA; Waldemar G; Minthon L; Blennow K
Arch Neurol; 2007 Mar; 64(3):366-70. PubMed ID: 17353378
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential CSF biomarkers in ALS.
Pasinetti GM; Ungar LH; Lange DJ; Yemul S; Deng H; Yuan X; Brown RH; Cudkowicz ME; Newhall K; Peskind E; Marcus S; Ho L
Neurology; 2006 Apr; 66(8):1218-22. PubMed ID: 16481598
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia.
Boban M; Grbić K; Mladinov M; Hof PR; Süssmair C; Ackl N; Stanić G; Bader B; Danek A; Simić G
Coll Antropol; 2008 Jan; 32 Suppl 1():31-6. PubMed ID: 18405055
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease.
Lee JW; Namkoong H; Kim HK; Kim S; Hwang DW; Na HR; Ha SA; Kim JR; Kim JW
BMC Neurol; 2007 Jun; 7():14. PubMed ID: 17565664
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease.
Finehout EJ; Franck Z; Choe LH; Relkin N; Lee KH
Ann Neurol; 2007 Feb; 61(2):120-9. PubMed ID: 17167789
[TBL] [Abstract][Full Text] [Related]
9. Proteome studies of CSF in AD patients.
Davidsson P; Sjögren M
Mech Ageing Dev; 2006 Feb; 127(2):133-7. PubMed ID: 16293296
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid neuron-specific enolase: a further marker of Alzheimer's disease?
Palumbo B; Siepi D; Sabalich I; Tranfaglia C; Parnetti L
Funct Neurol; 2008; 23(2):93-6. PubMed ID: 18671910
[TBL] [Abstract][Full Text] [Related]
11. [Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease].
Smach MA; Charfeddine B; Lammouchi T; Dridi H; Ben Othman L; Bennamou S; Limem K
Ann Biol Clin (Paris); 2008; 66(5):531-5. PubMed ID: 18957342
[TBL] [Abstract][Full Text] [Related]
12. Differential neuropsychological patterns of frontal variant frontotemporal dementia and Alzheimer's disease in a study of diagnostic concordance.
Giovagnoli AR; Erbetta A; Reati F; Bugiani O
Neuropsychologia; 2008 Apr; 46(5):1495-504. PubMed ID: 18262206
[TBL] [Abstract][Full Text] [Related]
13. Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels.
Soares HD; Chen Y; Sabbagh M; Roher A; Schrijvers E; Breteler M
Ann N Y Acad Sci; 2009 Oct; 1180():56-67. PubMed ID: 19906261
[TBL] [Abstract][Full Text] [Related]
14. Frontotemporal dementia: a clinically complex diagnosis.
Rosness TA; Haugen PK; Passant U; Engedal K
Int J Geriatr Psychiatry; 2008 Aug; 23(8):837-42. PubMed ID: 18302319
[TBL] [Abstract][Full Text] [Related]
15. IL-15 is elevated in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia.
Rentzos M; Zoga M; Paraskevas GP; Kapaki E; Rombos A; Nikolaou C; Tsoutsou A; Vassilopoulos D
J Geriatr Psychiatry Neurol; 2006 Jun; 19(2):114-7. PubMed ID: 16690997
[TBL] [Abstract][Full Text] [Related]
16. Prediction of Alzheimer's disease using a cerebrospinal fluid pattern of C-terminally truncated beta-amyloid peptides.
Höglund K; Hansson O; Buchhave P; Zetterberg H; Lewczuk P; Londos E; Blennow K; Minthon L; Wiltfang J
Neurodegener Dis; 2008; 5(5):268-76. PubMed ID: 18309230
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.
Parnetti L; Tiraboschi P; Lanari A; Peducci M; Padiglioni C; D'Amore C; Pierguidi L; Tambasco N; Rossi A; Calabresi P
Biol Psychiatry; 2008 Nov; 64(10):850-5. PubMed ID: 18395699
[TBL] [Abstract][Full Text] [Related]
18. Recent cerebrospinal fluid biomarker studies of Alzheimer's disease.
Choi YS; Choe LH; Lee KH
Expert Rev Proteomics; 2010 Dec; 7(6):919-29. PubMed ID: 21142892
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers for Alzheimer's disease.
Sonnen JA; Keene CD; Montine KS; Li G; Peskind ER; Zhang J; Montine TJ
Expert Rev Neurother; 2007 Aug; 7(8):1021-8. PubMed ID: 17678497
[TBL] [Abstract][Full Text] [Related]
20. Sugar chains of cerebrospinal fluid transferrin as a new biological marker of Alzheimer's disease.
Taniguchi M; Okayama Y; Hashimoto Y; Kitaura M; Jimbo D; Wakutani Y; Wada-Isoe K; Nakashima K; Akatsu H; Furukawa K; Arai H; Urakami K
Dement Geriatr Cogn Disord; 2008; 26(2):117-22. PubMed ID: 18654083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]